• Wildflower Brands is an integrated health and wellness company
• WLDFF offers a complete lineup of full-spectrum CBD-infused products
• The company recently signed a Polish distribution agreement

Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) develops and designs brands that focus on plant-based health and wellness products. Wildflower has an innovative and holistic business model that incorporates research and development (R&D), manufacturing, distribution, marketing and retail. The company’s brands include Wildflower Wellness and King Extracts. Wildflower Brands operates out of Washington State and California and sells across the United States.

Wildflower works in regulated cannabis markets in the United States in accordance with respective regulations, marketing its THC and CBD+ products. The company focuses on creating unique brands that work synergistically toward moving the company ahead to becoming an international wellness brand leader.

For example, Wildflower Wellness offers a comprehensive lineup of full-spectrum CBD-infused products made in the United States. The company’s California-based King Extracts centers on cannabis technology and delivery systems.

Wildflower Brands recently signed a distribution agreement with wholesaler Two Towers. Based in Poland, Two Towers is one of that country’s major wholesale prescription medical and over-the-counter wellness distribution companies (http://ibn.fm/pVulU). Two Towers distributes products from a wide-ranging list of worldwide leaders in pharmaceutical and consumer packaged goods. This distribution agreement advances Wildflower’s strategy for global growth and opens up expansion opportunities in the European Union.

Furthermore, Wildflower Brands is expanding its cannabis retail presence with City Cannabis Corp., a premier licensed cannabis retailer in British Columbia. Wildflower entered into a nonbinding letter of intent (LOI) last month to acquire City Cannabis in exchange for common shares of Wildflower Brands. City Cannabis holds two of the six City of Vancouver licenses to sell cannabis. It is the first company with multiple licenses in British Columbia (http://ibn.fm/07UGk).

This month, Wildflower Brands announced the signing of an agreement with Highmark Interactive to study the cognitive and functional neurological effects of cannabinoids via clinical research. The two companies will take advantage of Highmark’s industry-leading mobile software EQ – Active Brain Tracking. The aim of the research sponsorship is to create meaningful data and results, which could unlock new paths of understanding regarding the cognitive and functional neurological effects of cannabinoids (http://ibn.fm/swejm). A medical technology company, Highmark Interactive concentrates on assessing neurological functional performance and how it is affected after mild traumatic brain injuries and other neurological diseases.

“Wildflower continues to receive a flood of testimonials from consumers on our products that support wellness and health needs through plant-based solutions,” Wildflower Brands CEO William MacLean stated in a news release. “We always strive for improvements in our products and our understanding of those products, and this research commits us to that goal as an investment in the growth of our industry. Highmark Interactive brings the right skills and relationships to the table, and we are excited to see the results of our work together.”

Wildflower Brands is committed to creating and providing options for people seeking holistic wellness and health. For its customers, the company continues to study and develop better and improved ingredients and formulations. For investors, Wildflower offers the potential for portfolio growth with its precise global expansion strategy and dedication to superior products and a first-class consumer retail experience.

For more information, visit the company’s website at www.WildflowerBrands.co

• The company is constructing the first-ever cannabis mall, offering products manufactured in-house and serving outside vendors
• GCGX is reaching into the Lake Tahoe, California-area to provide products to more than 30 million who have limited or no access to recreational dispensaries
• The company is adding a medical grade nutraceutical division
• GCGX aims to commence the registration process for listing on the Nasdaq, with a target date of mid- to late-June

Headquartered in Florida, Global Consortium Inc. (OTC: GCGX) is a diversified, cannabis-holding company expanding its reach nationwide. The company’s portfolio includes several subsidiaries, partnerships and licensing agreements. Focused on sustainable revenues from operations, GCGX’s approach is seed to shelf, thereby providing the company with optimal control of the end-consumer experience. The company believes that the first to market will dominate and is pushing its way to the forefront.

The company is currently constructing the first-ever cannabis mall. Located in Sacramento, California, this 64,000-square-foot building will follow GCGX products from seed to sale. Manufacturing, distribution, delivery, retail, testing and cultivation operations are all expected to take place under the same roof. Once completed, the cannabis mall will be home to the largest operational CBD and THC distillate and edible manufacturing facility in the country. The mall will offer products manufactured in house, as well as serving outside cannabis vendors.

GCGX is reaching into the Lake Tahoe, Nevada, area to establish itself as one of the first in the recreational space. The area has no recreational dispensaries, and the more than 30 million people who live and visit Lake Tahoe rely on a single licensed delivery company. All of Global Consortium’s products are now available in the area, and the weekly order placed is worth a minimum of $50,000.

The Global Consortium product line currently consists of Infused Oils and Infused Edibles. The company’s Infused Oils line creates natural, pesticide-free, medicinal cannabis extracts that are strain-specific THC and CBD oils of premium quality. In its 13 years of production, the company’s Infused Edibles line has received 17 first-place awards for its U.S.-grown and CBD-infused products and currently serves an estimated 400 stores in 15 states. The production of all edibles is expected to relocate by the end of Q2 2019 to the new cannabis mall (http://ibn.fm/54BSn).

The company also recently announced (http://ibn.fm/6zZsa) that it is adding a medical grade nutraceutical division. Products produced from this division will be overseen by medical doctors and veterinarians, and they may include lotions, balms, ointments, liquids, pills and powders. While some products will be made available to the public, others will be white labeled for customization to providing doctors’ practices.

During a recent investor conference call (http://ibn.fm/pVmEu), GCGX CEO Matthew Dwyer also emphasized the company’s goal to begin the registration process for being listed and traded on the Nasdaq by mid- to late-June.

For more information, visit the company’s website at www.GCGX.org

NOTE TO INVESTORS: The latest news and updates relating to GCGX are available in the company’s newsroom at http://ibn.fm/GCGX

• Figures from VPR Brands’ 2018 report point to strong financial performance
• VPR Brands’ growth strategy focuses on high-performance, high-quality products that build expanded brand quality, awareness and loyalty
• The company’s plethora of brands target multiple corners of the lucrative cannabis industry

VPR Brands, LP (OTC: VPRB), an innovative technology holding company whose assets include patented atomization-related products and technology, recently announced its 2018 financial results, boasting increased revenues and a net operating gain.

The company has grown its revenues to almost $4.6 million (http://ibn.fm/Wsh4U) while “reversing its operating loss of over $888,000 to positive territory above $9,000.” Its full-year operating margins grew by almost 20 percent from 2017 to a margin of 441 percent in 2018.

VPR Brands CEO Kevin Frija noted the company’s efforts to maintain growth while being fiscally responsible. In a news release, he stated, “We have all tirelessly worked to build a strong foundation and prove we are capable of maintaining consistent and sustainable growth and still be mindful of financial performance.”

Figures from VPR Brands’ report point to strong financial performance. Operating expenses for full-year 2018 went down from $2,100,901 to $1,905,881, as compared to full-year 2017. Despite this decrease, the company was able to increase revenues by 28 percent for the same period, from $3,610,379 to $4,613,300.

VPR Brands’ growth strategy focuses on high-performance, high-quality products that build expanded brand quality, awareness and loyalty. The company boasts a strong portfolio featuring various brands geared toward multiple sectors of the cannabis and CBD-oil industries.

VPR Brands’ GoldLine utilizes the latest technology to create premium edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. Honeystick, a lifestyle brand, tailors its upper-tier vaporizers to the needs of patients and recreational users, and it is sold both online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops.

GoldLine Hemp products, on the other hand, are created without CBD for consumers who aren’t looking for CBD offerings but still want to take advantage of this rapidly expanding class of products. GoldLine’s hemp-only edible hemp gummies are now being distributed nationwide.

This small sampling of VPR Brands’ portfolio shows its industry range and versatility. VPR Brands continues to expand its industry presence by focusing on cutting-edge technology and user-centric designs that are uniquely engineered to be used with cannabis or CBD oils, concentrates and flowers.

For more information, visit the company’s website at www.VPRBrands.com

NOTE TO INVESTORS: The latest news and updates relating to VPRB are available in the company’s newsroom at http://ibn.fm/VPRB

• A recently introduced informercial campaign tells the real-life story of the impact of ETST cannabinoids on consumer
• An estimated 64.5 percent of hemp-sourced cannabis is sold online; the legal cannabis market is projected to hit $20.2 billion by 2021
• The ‘As Seen on TV’ spot is currently airing on Fox News, Lifetime and the Cooking Channel

Earth Science Tech Inc. (OTCQB: ETST), a biotech company focused on the nutraceutical and pharmaceutical fields, is inviting viewers of its ‘As Seen on TV’ infomercial aired in the New York market to purchase ETST’s industrial-grade, hemp-sourced cannabinoid products online. According to a study by the Brightfield Group, almost two-thirds, or 64.5 percent, of hemp-sourced cannabis is bought online (http://ibn.fm/Oj3Um). ETST is exactly on target with the market.

The 60-second commercial also invites viewers to buy ETST products at local health food stores. A Forbes article reported that, while the internet was first in sales of hemp-sourced cannabinoids, health stores were also a leading source, coming in fourth. Other purchasing options include smoke shops (second), dispensaries (third) and doctors’ offices (fifth).

The infomercial is introduced by Kevin Harrington, identified as an original shark on the TV Show Shark Tank. He explains that ETST’s full-spectrum cannabinoids can help the “aches or pains” issue (http://ibn.fm/p83vz). The spot then tells the success story of real-life customer Rhoda Friedman, who credits her improvement in mobility and lifestyle to ETST’s full-spectrum cannabinoids. As the infomercial ends, viewers are invited to buy ETST products, either online or at a local health food store.

ETST’s full-spectrum cannabinoids offer analgesic pain relief and anxiety reduction, per company data. ETST offers cannabinoids in the form of soft gels, tablets, liquids and other options classified as food-based and permissible in all 50 states in the United States and some 40 countries.

Initially, the spot is airing in New York between 9 p.m. and midnight ET, but ETST has announced that more markets and networks will be added to the infomercial campaign, which is scheduled to run through July 14. First airing on Fox News, Lifetime and the Cooking Channel, the spot may also be seen online on various social media platforms.

Arcview Market Research projects that legal cannabis sales in North America will reach $20.2 billion by 2021, growing at a compound annual growth rate of 25 percent from 2016 (http://ibn.fm/0L9ml).

For more information, visit the company’s website at www.EarthScienceTech.com

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST

• Supreme Cannabis recently released its Q3 2019 financial results
• Health Canada recently approved Supreme Cannabis’ 7ACRES facility for an additional 50,000 square feet of production capacity
• Market analysts describe Supreme Cannabis as “One of the more interesting small cap investments”

The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1), a leading licensed cannabis producer with a diversified portfolio of products and brands, is making significant headway in the cannabis industry and expanding its production capacity.

The Supreme Cannabis Company recently announced the release of its third-quarter financials, the results of which indicate strong revenue growth achieved through a combination of several factors: expanded capacity at the company’s 7ACRES production facility, expanded product packaging and a desire for high-quality cannabis driven by consumers. “Our company is pleased with the results of our third-quarter financials and with the progress made thus far on our strategic priorities for the 2019 calendar year,” Supreme Cannabis CEO Navdeep Dhaliwal stated in a news release (http://ibn.fm/OcubI).

Dhaliwal reflected on the company’s first six months of legal cannabis sales in Canada, noting that Supreme Cannabis “was originally viewed as a contrarian for taking a consumer-oriented approach to the cannabis market.” Despite this, he praised consumers’ ability to ultimately shape the market’s trends, as 7ACRES has received strong consumer feedback. 7ACRES brands have positioned the company as a top-10 revenue producer in the industry as well, earning it recognition as a “coast-to-coast, award-winning premium brand.”

The company’s impressive Q3 2019 financials report a 382 percent increase in net revenue from Q3 2018, growing from $2.1 million to a staggering $10 million. Over the quarter, sales revenue from adult-use recreational markets increased by 63 percent.

The future of Supreme Cannabis’ industry growth looks particularly promising as well, as Health Canada recently approved its 7ACRES facility for five additional flowering rooms, signifying an increase of 50,000 square feet of production capacity (http://ibn.fm/MuX69). “With five more flowering rooms at 7ACRES… the finish line is now in sight,” company Founder and President John Fowler stated in a news release. Noting that the company’s goal for 7ACRES is to reach full production capacity once all 25 flowering rooms are licensed, Fowler added, “We are excited to fulfill demand for our high-end cannabis from enthusiasts coast to coast.”

Merrill Lynch research analysts Christopher Carey and Lisa Lewandowski recently noted Supreme Cannabis’ impressive results. “We think Supreme is setting up as one of the more interesting small cap investments in the cannabis sector,” they wrote in an update. They credited the company’s “international expansion strategy” as harboring untapped potential, describing it as “an underappreciated catalyst.”

“Supreme is executing; and, with a sound strategy in Canada (focus on premium tier), global optionality, and reasonable valuation, we believe it could prove as more [sic] of the more interesting plays in cannabis,” the pair reported.

For more information, visit the company’s website at www.Supreme.ca

• Black Iron and Ukraine’s National Railway have signed an updated letter of intent, securing transportation capacity for the iron ore to be derived in the future from the Shymanivske project
• As Black Iron comes closer to initiating Shymanivske construction, it is renewing letters of intent for all of the vital infrastructure that will be required for the mining and transportation of iron ore
• The company is also carrying out discussions with banks and financial entities to secure the financing necessary to commence construction and mining at a time when iron ore prices continue to climb

Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) has renewed a letter of intent with Ukraine’s national railway that will secure transportation capacity for the iron ore derived from the Shymanivske Project. As per the terms of the agreement, the national railway will transport product from the project’s mine site to the Black Sea Port of Yuzhny, according to a company press release (http://ibn.fm/Dnnze).

This announcement once again confirms the ready accessibility and the benefits resulting from the well-established infrastructure in the region.

The Shymanivske iron ore project has access to premier infrastructure, including nearby electrical power, railway and five seaports. Most of the iron ore development projects across the globe necessitate the costly construction of rail, power lines and/or deep seaport at significant cost. Rail, for example, costs roughly $3 million per mile, while powerlines cost $1 million per mile and deep seaports can easily eclipse a few hundred million to construct. Since most iron ore projects are located several hundred miles from rail and/or power, building this major infrastructure can easily cost several hundreds of millions prior to even building the mine and processing plant, resulting in total project costs of well over $1 billion. These issues are eliminated in Black Iron’s case through the availability of all required infrastructure in the Shymanivske region. In addition, Black Iron can benefit from the cost-efficient and skilled workforce available for hire.

As Black Iron is coming closer to initiating construction, it is renewing letters of intent for vital infrastructure like rail, power and port capacity.

“Renewing the LOI with Ukraine’s National Railway is an important step in providing assurance to current and future investors in our Project. We are very fortunate to be able to access such high-quality infrastructure which is right on the doorstep of our Project. We appreciate the close cooperation we have received from all levels of government in Ukraine and from the National Railway,” Black Iron CEO Matt Simpson said in a news release.

Apart from focusing on infrastructure availability, Black Iron is also working to secure funds for Shymanivske construction on the back of announcing an offtake and investment memorandum of understanding with Glencore. The company is carrying out finance discussions with export credit agencies, European banks, royalty/stream companies and private equity firms. The ultimate goal is to secure the required debt and equity funding package to initiate construction.

Black Iron’s Shymanivske Project is located in Ukraine’s Kryvyi Rih region. The area is highly developed and has established iron ore mining traditions.

Upon finalization of construction, the project is expected to produce ultra-high-grade 68 percent iron ore concentrate with few impurities at low production costs. This fact, combined with the strong demand for high-grade iron ore that will potentially grow even further in the future, results in a high anticipated return on investment from Shymanivske.

In May 2018, a CRU analysis suggested that Black Iron’s Shymanivske iron ore project ranks at the lowest position of the business cost curve and at the second-lowest position on the basis of capital intensity out of all global underdeveloped pellet feed iron ore projects.

The technical and scientific contents of this article have been reviewed and approved by Matt Simpson, P.Eng., CEO of Black Iron, who is a Qualified Person as defined by NI 43-101.

For more information, visit the company’s website at www.BlackIron.com

NOTE TO INVESTORS: The latest news and updates relating to BKIRF are available in the company’s newsroom at http://ibn.fm/BKIRF

• The company aims to promote healthier administration methods, eliminating the need for sweeteners to mask taste
• Lexaria’s mission is to save lives with its technology, which allows for delivery of drug molecules through ingestible means
• The company is seeing high demand in North American markets for DehydraTECH in cannabis-infused beverages
• Lexaria recently announced its entry into a CBD-beverage formulation license agreement with a Nevada-based company

Traditionally, consumers have relied on smoking to achieve higher absorption rates and fast onset of bioactive compounds such as nicotine and cannabinoids. Ingesting drugs and molecules through edibles is simply safer than inhaling them. However, the absorption of edibles has proven slow, and the taste can be unpleasant without the aid of sweeteners.

Now, thanks to a revolutionary oral technology, it is possible to deliver bioactive substances via oral ingestion without the need for the unhealthy practices of inhalational or added sweeteners.

Biotechnology company Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) has developed and out-licenses its drug-delivery platform, DehydraTECH, promoting healthier administration methods. This revolutionary oral technology increases the product’s absorption rate, reduces the time of onset and masks the undesirable taste, thus eliminating the need for sweeteners in edibles. The overall dosing is lowered, and the effectiveness of ingestible drugs and other beneficial molecules is increased. The technology offers the consumer the benefits of ingestion without the related risks that come with smoking.

“Lexaria Bioscience has the actual opportunity of changing the world,” LXRP CEO Chris Bunka noted on CEO Clips via YouTube (http://ibn.fm/cQqEd). “We can do it through saving lives, making health improvements for any number of people who are ingesting any number of drugs or molecules like pain relief, cannabinoids or nicotine. Everybody knows that smoking is not healthy. Our technology allows for the delivery of drug molecules like cannabinoids or nicotine through ingestible means, things that you swallow. It could be a pill, a syrup or a cup of coffee. That technology, which is called DehydraTECH, is optimized to carry that drug across the intestinal wall and get more of it into your bloodstream more quickly than it otherwise could.”

Lexaria is the only company worldwide with a patent issued for oral delivery of all cannabinoids. The company currently has 10 patents granted for its cost-effective DehydraTECH, with 53 patent applications filed and pending in more than 40 countries worldwide. Lexaria is anticipating additional patents in the coming years as its intellectual property portfolio continues to grow. By out-licensing DehydraTECH, the company anticipates a steady stream of royalties from start-ups, as well as a Fortune 100 company.

Lexaria continues to see high demand in the North American markets for use of DehydraTECH in beverages. The cannabis-infused and CBD beverage markets in the United States are exploding. According to an article from Business Insider (http://ibn.fm/1EROT), the industry could reach $600 million in the United States by 2022, outpacing other cannabis products by more than two times.

Lexaria Hemp Corp., a subsidiary of LXRP, recently announced that it has entered into a definitive five-year agreement with a Nevada-based company to provide the patented DehydraTECH for use in certain CBD-based beverages (http://ibn.fm/FlDSU). These beverages are expected to be produced and sold across the United States.

For more information, visit the company’s website at www.LexariaBioscience.com

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

• Soliton is positioning its proprietary technology as a new standard of care in the multimillion-dollar tattoo-removal industry
• The company recently filed a 501(k) with the FDA for its Rapid Acoustic Pulse tattoo-removal device
• Soliton’s cellulite reduction clinical trials have been featured on Yahoo Finance’s First Trade live stream

Medical device company Soliton Inc. (NASDAQ: SOLY) plans to launch its Rapid Acoustic Pulse (RAP) device into the tattoo-removal market, positioning it as the new standard of care. The company also plans to complete its fat and cellulite reduction trials by 2023. The valuable new RAP technology is licensed from the University of Texas on behalf of the MD Anderson Cancer Center. The RAP device is covered by eight patent families representing 38 issued or pending patents worldwide.

Tattoo removal is on the rise, and the surrounding industry is forecast to reach $4.8 billion by 2023. Laser therapy holds 66 percent of the market but is time consuming and costly (http://ibn.fm/8n9rm). Typical laser treatment for tattoo removal results in an 11-16 percent reduction in pigment and requires 10 to 20 visits over a two-year period for the complete removal of the tattoo because of the body’s reaction to the treatment and the need for healing between appointments.

The conventional method is painful, damages the skin and lacks predictable results; the method also costs up to $3,500 or more. When using the RAP device, multiple laser passes can be performed in a single-treatment session. This reduces visits down to two or three for tattoo removal, which also reduces the cost.

In a recent clinical study, 100 percent of the tattoos treated with Soliton RAP achieved 75 percent fading in three or fewer office visits, supporting the company’s claim of being three or more times faster than conventional methods. The RAP device uses very high energy — around 3,000 volts at nearly 3,000 amps — to form acoustic shockwaves 100 times per second. The acoustic waves are virtually painless, do not damage the skin and are divergent, thus eliminating heat. Soliton recently filed for a 501(k) with the FDA for its RAP tattoo-removal device (http://ibn.fm/RKmEt), which is not currently available for sale.

Soliton has a strong commitment to science and is conducting animal and human trials to confirm the safety and efficacy of the technology. The company believes in transparency, and the results of its clinical trials can be found on its website at www.Soliton.com. The technology is currently undergoing fat clinical trials and a cellulite reduction trial.

Soliton recently announced that its manufacturing partner has delivered the first replaceable cartridge targeting cellulite reduction (http://ibn.fm/CSr81). This cartridge delivers the high-powered acoustic pulses at even greater depths than the tattoo-removal cartridge.

“We are very enthusiastic about the flexibility that our interchangeable treatment heads will bring to the practitioners that partner with us for the treatment of cellulite reduction and tattoo removal,” Dr. Chris Capelli, Soliton president, CEO and co-founder, stated in a news release. “Our therapy will be delivered through single-use cartridges that are designed to be used for one patient treatment. Once our device is cleared by the FDA, we expect to deliver a recurring revenue stream and drive top-line growth for the company.”

On May 13, 2019, Soliton was featured on First Trade, the new live-streaming Yahoo Finance show (http://ibn.fm/WP4sg). The focus during the segment was on the newly released cellulite clinical trial data. Soliton is strategically positioned to serve a global market combating cellulite, which is estimated to reach $1.4 billion by 2026.

For more information, visit the company’s website at www.Soliton.com

• IONIC Brands offers investors exposure to a portfolio of luxury brands including IONIC vaporizer pens, Zoots edibles, Vuber Technologies and Vegas M Stick vaporizer pens
• IONIC expects recent acquisitions to add more than $30 million in revenue in 2019 with total revenues projected at $46 million
• Top 10 vape pen company in Washington state; application of proven sales and marketing formula offers massive growth opportunity in multiple states
• Vertical integration with diversification of products and product segments includes 11 cannabis licenses in three states
• IONIC brands are now sold in six states in 685 stores
• Over $34 million in organically-generated sales since 2015-2018

IONIC Brands Corp. (CSE: IONC) (OTC: ZRRRF) is a national cannabis holding company building a multistate portfolio of award-winning premium and luxury brands in the cannabis space. Established in 2015, IONIC Brands has demonstrated its ability to expand and operate multiple cannabis concentrate consumer brands in markets across the western United States. The company continues to strategically expand nationwide to remain a leader of the highest-value segments in the cannabis market.

With a focus on quality, responsibility and respectability, IONIC’s product lines are pioneering the changing landscape of cannabis consumption. The company’s refinement practices are a result of a passionate commitment to craft the finest, small-batch cannabis oils and cannabis concentrates in the world – without glycols, glycerins or additives.

IONIC’s Certified Clean program verifies that every product leaving the company’s facilities meets or exceeds state mandates on pesticide testing. The testing is conducted by individually testing every batch which ensures and enhances trust and transparency. IONIC recently paired its Certified Clean program with Lucid Green Inc. and its revolutionary technology platform designed to provide vital safety information. Lucid Green’s technology provides a direct-to-consumer data platform, providing instant access to a library of product specific insights by simply scanning the package’s QR code with a smartphone camera.

Elite Brand Portfolio/Acquisitions

• IONIC, the company’s flagship recreational branded product, is a stylish and sophisticated premium vape pen line that has earned customer loyalty and a reputation as a consistent Top 10 vape brand in Washington state. IONIC’s immediate product line expansion plans include THC/CBD mixes, low-dose products, high-end edibles, CASK oil and device innovation.
• WW Agriculture cultivates cannabis outdoors on a 140-acre eastern Washington State farm capable of producing up to 100,000 pounds of cannabis for less than $0.10/gram.
• ZOOTS, a Washington-based edibles company, utilizes patent-protected ultra-clean CO2 extraction hardware to create proprietary formulations of refined cannabis oils and distillates. Through MedMen dispensaries, Zoots Edibles are currently available in Washington and Colorado and will soon be on shelves at dispensaries in Massachusetts, New York and Pennsylvania.
• Vuber Technologies hardware produces the best vaporization experience on the market.
• Vegas M Stick vaporizer pens are distributed to stores in Washington State with plans to expand to Oregon and Nevada.
• Vegas Valley Growers is a revenue-generating, vertically integrated operation in Las Vegas, Nevada, with a full complement of production, manufacturing and distribution licenses.

IONIC has also acquired two U.S. patents issued to Canna Café that are related to cannabinoid (CBD) infused coffee and CBD-infused coffee in a Keurig ® K-Cup ® Pod. An international patent is in process for cannabis-infused teas.

Experienced Management Team

IONIC Brands is led by an innovative product team, powerful sales organization and a world-class marketing group.

Chairman & CEO John Gorst has built and sold four different technology companies with market valuations in excess of $600 million. Gorst has been at the forefront of IONIC’s expansion and development into Washington state’s leading vaporizer brand.

Andrew Schell, President, Vice-Chairman & Co-Founder, has built several successful companies. Schell has an engineering background rounded in operations, strategy and corporate law, and most recently was CEO of a U.S. Department of Defense company specializing in military operations.

Christian Struzan, Chief Marketing Officer & Co-Founder, has over 30 years of experience in marketing and branding in the entertainment and consumer goods industries. Struzan founded an advertising agency which developed and executed marketing campaigns for feature films such as the Star Wars franchise, Fight Club, and the television series American Idol. He has also worked on global brands such as Guinness, Stella Artois and Beck’s.

Johnny Stange, Chief Revenue Officer, was formerly a director of sales for the southern California region for Treasury Wine Estates, a major wine wholesaler, where he grew and oversaw annual sales of $250 million. Stange is leading the charge in IONIC’s aggressive sales growth plans across multiple states.

In 2018, IONIC was voted one of the “Top 50 Companies to Work for in Cannabis” by MG Magazine, a publication serving cannabis industry professionals.

For more information, visit the company’s website at www.IONIC.social

NOTE TO INVESTORS: The latest news and updates relating to ZRRRF are available in the company’s newsroom at http://ibn.fm/ZRRRF

• Black Iron is working to fund the launch of its wholly owned Ukrainian iron ore project by the end of the year, recently closing a more than $1.5 million private placement
• Iron ore market prices continue climbing amid supply setbacks elsewhere in the world, and some analysts anticipate the possibility of $100 per metric ton soon
• Ukraine’s Kryvyi Rih region is one of the country’s most prolific for iron deposits, spawning a number of mines and processing facilities

Mine developer Black Iron Inc. (TSX: BKI) (OTC: BKIRF) (GR: BIN) continues to foresee a great potential opportunity in rising iron market prices as the company’s 100 percent-owned development project in Ukraine’s Kryvyi Rih region tries to secure essential land and funding for construction, and its efforts are gaining national media attention.

Black Iron’s work to start building a mine operation at its Shymanivske project is held up by the need to obtain the surface rights at the central Ukraine site. This includes land held by Ukraine’s Ministry of Defense (“MOD”) that is directly adjacent to Black Iron’s ore body. The MOD uses the site for training purposes, but it is in discussion with company management to relocate some of its facilities to free up sufficient land to meet Black Iron’s needs.

Iron ore prices have been on an upward trajectory because of production cutbacks related to short-term adverse natural events in Australia and the apparently longer-term disruptions in Brazil caused by the failure of a tailings dam at the beginning of the year and subsequent concerns about other dams in the region. Ongoing legal hurdles have continued to drive down output forecasts amid unsuccessful Vale SA (NYSE: VALE) efforts to resume iron ore operations (http://ibn.fm/jpzxN), fueling projections that iron ore could soon top $100 per metric ton.

Toronto-based industry publication The Northern Miner has followed developments in Kryvyi Rih, and last year’s report (http://ibn.fm/1JtWC), titled ‘Site visit: Black Iron advances Shymanivske premium iron ore project in Ukraine’, has been selected as a finalist in the inaugural National Magazine Awards launched by the National Media Awards Foundation to recognize excellence in business-to-business (B2B) journalism.

A panel of 62 judges nominated 95 entries from 34 B2B publications in more than a dozen categories, and the article on Black Iron’s progress is listed among nine finalists for the ‘Best Profile of a Company’ award (http://ibn.fm/1b1Qa). The winners will be announced on May 29 at the awards luncheon at Toronto’s One King West Hotel. Black Iron applauds reporter John Cummings for this story and wishes him luck at the awards.

Kryvyi Rih is one of Ukraine’s largest centers of metallurgical activity. The 62-mile long city is ringed by quarries, iron mines, steel and coke-processing facilities, given the region’s rich iron ore deposits. Black Iron has completed a NI 43-101-compliant resource report and a preliminary economic assessment, which estimates that the site has 646 million tons of measured and indicated mineral resources, plus 188 million tons of inferred resources supporting a 20-year mine life.

In April, the company upsized and closed the final tranche of a non-brokered private placement funding effort to raise over $1.5 million in favor of the project, which was labeled the lowest-cost undeveloped pellet feed project globally by metals consultancy CRU (http://ibn.fm/AMg9w). The main use of proceeds from this raise will be to secure funding from institutional investors that have expressed interest in backing construction of Black Iron’s Shymanivske project and land surface rights for the mine, concentrator, tailings and waste rock piles.

For more information, visit the company’s website at www.BlackIron.com

NOTE TO INVESTORS: The latest news and updates relating to BKIRF are available in the company’s newsroom at http://ibn.fm/BKIRF